Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

BJA PDMP Funding Announced

Posted 5/20/2023

WASHINGTON ? May 18, 2023 - The FY 2023 Harold Rogers Prescription Drug Monitoring Program (PDMP) solicitation is now available.

The goal of the Harold Rogers PDMP is to support state and local governments in detecting and preventing the diversion and misuse of pharmaceutically controlled...
Read More

DEA Seeks Assistance From PMP Programs in Establishing Aggregate Production Quotas

Posted 5/2/2023

The US Drug Enforcement Administration (DEA) has reached out the National Association of State Controlled Substances Authorities (NASCSA) to seek the assistance of state Prescription Monitoring Programs in establishing aggregate production quotas (APQs) for certain drugs as required by Congress.<...
Read More

CDC Job Announcement - Associate Service Fellow or Senior Service Fellow

Posted 4/16/2023

The Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control (NCIPC), Division of Overdose Prevention (DOP), Health Systems and Research Branch is recruiting a full-time Associate Service Fellow or Senior Service Fellow position as a Health...
Read More

FDA Announces New Safety Label Changes For Opioid Pain Medicines

Posted 4/14/2023

The FDA is requiring several updates to the prescribing information for immediate-release (IR) and extended-release/long-acting (ER/LA) opioid analgesics. The updates also include a new warning about opioid-induced hyperalgesia (OIH) which is a condition where opioids cause an increase in pain...
Read More

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Posted 3/30/2023

Agency Continues to Take Critical Steps to Reduce Drug Overdose Deaths Being Driven Primarily by Illicit Opioids


Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways


COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us.

Please use this form to contact Alexandra Blasi

* Please do not submit patient health information (PHI).